Team
Enoumena Therapeutics is driven by a committed team of highly experienced professionals, united by a singular focus on advancing patient health through rigorous science and ethical practice.
Peter Melnyk, PhD
Founder, President & CEO
Peter Melnyk is a leader in the life sciences and pharmaceutical industry with over 25 years of experience. With a PhD in Pathology from McGill University, his career began with a focus on cardiac arrhythmias at the Montreal Heart Institute. This early work fueled his passion for healthcare innovation, leading to a career dedicated to improving access to new therapies.
He held leadership roles at Novartis and Otsuka before founding Enoumena Therapeutics, which brings impactful solutions to Canadian patients and healthcare providers through strategic partnerships and collaborations. Peter also serves on the Board of Directors of the Canadian Association for Healthcare Reimbursement.
Foundation
Deep Canadian experience.
Our structure ensures that every critical function is led by experts with significant, established track records. Every member of our team is a Canadian professional, with an inherent understanding of the Canadian regulatory, healthcare and business landscape.
Expertise
Specialized functional expertise.
- Medical affairs & medical informationDriving scientific communications and ensuring accurate, balanced data dissemination.
- Drug safety & pharmacovigilanceMaintaining the highest standards of patient safety and continuous monitoring of our therapeutic programs.
- Legal affairsExpert counsel on pharmaceutical law, regulatory compliance and corporate governance.
Experience
25+
years of industry-specific experience brought by each member of our core team, ensuring knowledgeable leadership and strategic excellence.